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Two types of complementary DNA clones for rat brain protein kinase C were isolated. These clones encode 
671 and 673 amino acid sequences, which differ from each other only in the carboxyl-terminal regions of 
approx. 50 amino acid residues. This difference seems to result from alternative splicing. Elucidation of the 
sequences of these cDNA clones as well as some peptides from the purified rat brain enzyme suggests the 
existence of an additional species of protein kinase C in this tissue. It is attractive to imagine that the hetero- 
geneity of protein kinase C may reflect diverse pathways of signal transduction into the cell. 
Protein kinase C complementary DNA 
1. INTRODUCTION 
Protein kinase C has attracted great attention in 
the studies on the activation of cellular functions 
and proliferation, since this enzyme appears to 
play key roles in signal transduction for a wide 
variety of biologically active substances [l-j]. This 
protein kinase consists of a single polypeptide 
chain with an approximate M, of 77000, and the 
enzymes from various tissues of animals are ap- 
parently similar to one another in their kinetic and 
catalytic properties [4]. However, the enzyme 
isolated from rat brain soluble fraction frequently 
reveals a double band upon SDS-polyacrylamide 
gel electrophoresis [5]. This raises the possibility 
that the gene of protein kinase C may be multiple. 
In our earlier report [6] partial amino acid se- 
quences of the peptides derived from rat brain pro- 
tein kinase C were determined, and a cDNA clone 
encoding the carboxyl-terminal region of this pro- 
tein kinase was isolated using oligonucleotides 
deduced from the amino acid sequences as probes. 
Nucleotide sequence Alternative splicing 
The amino acid sequence predicted from the 
nucleotide sequence of this cDNA clone revealed a 
significant homology to other serineithreonine 
protein kinases [6]. In this paper, we wish to report 
the complete primary structures of two types of rat 
brain protein kinase C, that can be predicted from 
nucleotide sequences of several overlapping cDNA 
clones, and to discuss that the two types of cDNAs 
might be derived from the messages which result 
from alternative splicing. 
2. MATERIALS AND METHODS 
2.1. cDNA libraries 
Plasmid cDNA library was constructed using rat 
brain poly(A)+ RNA by the procedure of 
Okayama and Berg [7] as described [6]. Phage 
cDNA library was constructed with XgtlO vector 
syst’em [8] as follows: the first strand was primed 
oligo(dT), and the second strand was made with 
RNase H and DNA polymerase I. The double- 
stranded’ cDNA was treated with T4 DNA 
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polymerase, methylated on internal EcoRI sites 
with EcoRI methylase, and ligated to EcoRI 
linkers with T4 DNA ligase. After double-stranded 
cDNA was passed through a Bio-gel A5Om col- 
umn, it was cloned in AgtlO phage. Starting from 
10 pg of rat brain poly(A)+ RNA, 1.5 x lo6 in- 
dependent phage clones were obtained. Sequential 
plaque screening was carried out according to 
Maniatis et al. [9] using each nick-translated 
restriction endonuclease fragment as probe. 
2.2. Nucleotide sequencing 
Nucleotide sequence analysis was performed us- 
ing the enzymatic chain termination method in 
conjugation with M13-derived vectors as described 
in [a]. 
3. RESULTS AND DISCUSSION 
3. I. cDNA clones 
As described in [6], a cDNA clone, which en- 
codes the carboxyl-terminal region of rat brain 
protein kinase C, has been isolated from the rat 
brain cDNA library by the colony hybridization 
procedure with synthetic oligonucleotides as 
probes. This cDNA clone, designated pCKR9 
(fig. l), encodes the carboxyl-terminal region 
covering about one-third of the entire cDNA for 
this enzyme. To isolate the cDNAs which may en- 
code the amino-terminal region of protein kinase 
C, a 0.7 kb PstI fragment of pCKR9 was prepared 
and employed as probe to rescreen the plasmid 
library. No cDNA that was longer than pCKR9 
was isolated from the library, except for cDNA 
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Fig. 1. Schematic representation of rat brain protein kinase C cDNA clones. Overlapping clones and schematic diagrams 
of two types of the complete cDNA structures are given. Thin lines and boxes indicate the untranslated regions and 
coding regions, respectively. Cross-hatched regions indicate divergent regions between type I and type II of protein 
kinase C. Several restriction endonuclease cleavage sites are shown on each cDNA clone: E, EcoRI; H, HindIII; P, WI; 
Bg, BgllI. 
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clones containing an unspliced intron (see below). 
Therefore, a new library was constructed with 
the AgtlO vector system using poly(A)+ RNA that 
was obtained from rat brain. Upon screening 
against the hgtl0 cDNA library with the 0.7 kb 
PHI fragment as probe, two types of cDNA 
(hCKR108 and ACKR107) were isolated. Both 
cDNA inserts were strongly hybridized to the 
probe, but the patterns of restriction endonuclease 
digestion were slightly different. Thus, the two 
types of cDNA were designated as type I and type 
II, respectively. Analysis of the nucleotide se- 
quences of these two clones revealed that the 
ACKR107 insert contained an additional 216 
nucleotides to the ACKR108 insert at position 2547 
(fig.2). This ins&on appeared to be derived by 
alternative splicing (see below). These cDNA 
clones both contained a 3 ’ -untranslated region of 
about 500 nucleotides for type I and 700 
nucleotides for type II, and were not long enough 
to code the entire protein kinase C molecule that is 
estimated to have an M, of 77000 [4]. 
In order to obtain further the 5’-sequence, the 
hgtl0 cDNA library was rescreened with a “P- 
labeled EcoRI-BglII 0.5 kb fragment obtained 
from ACKR107. Three additional cDNA clones 
were isolated which extended to the 5 ‘-termini 
(XCKR152, XCKR166 and hCKR172). Fig.1 shows 
the series of overlapping clones covering the entire 
coding region of protein kinase C. 
3.2. cDNA sequences 
The complete nucleotide sequence of rat brain 
protein kinase C is shown in fig.2. Starting at the 
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AGGCTCTCTCAAACTTCTGCCGCAGCTCTTCATTGCCCTCGCTTCCTTCCGGCGGCACCGGCACATTAAAGTACTCGCCTTCTTCCTGGCTTAGTAACTTGAACCCTCATCTCCTTGAAC 120 
CTTCGGGTACTTAGGCGTTCAATCCTTTCTTGGGCACCCGAGGTGCTCATCTTAACGCACCCCAGGGCCTAGGACAGGGTGCCAGGGGCGCGGCTCAGATCTGTCCAGCGCAGTCTGCGG 240 
TCCTCGCGCCGCAGCGTGCGGCTAAGAACACTTGGCTGGGGGGCCTGCGGGTTGCGGTGTGTGTGTATATGTGTGTGTGTCTGAGTCTGTGTGTGCGTTTGCTGGTGGTGCCGATATGTA 360 
AAGCAGCTGGCGGCTCTGGGCGGGGCCTGGGTTCCATGCAAATGAAGGAGGAGGGGCTACCCTGGGGCTCCGCCTCCCTCCCCCGCAGCTGGGGCCAGCGGTGCCAAGCACAGCTGGACC 480 
AGCGGCAGCAGCTGGGCGAGTGACAGCCCAGCAACGCGCGCGCGGCCGCCGCCAGAGCCGGCGCGAAGGGGCAGCGCGGCCCTGCGGTCCCCGGGCGGCAGCAGCGGCCGCCTAGTCCCG 600 
CGCCTCTCCGGGCTTACAGCCCCCGGTCCCGCCGCCCCGGGGCCGCCACCTCTCGGGGCTCCCCCCAGTCCCCGCGCGCGCAAGATGGCTGACCCGGCTGCGGGGCCGCCGCCGAGCGAG 720 
MetAlaAspProAlaAlaGlyProProProSerGlu 12 
GGCGAGGAGAGCACGGTGCGCTTCGCCCGCAAAGGCGCCCTCCGGCAGAAGAACGTGCACGAGGTGAAGAACCACAAATTCACCGCCCGCTTCTTCAAGCAGCCCACCTTCTGCAGCCAC 840 
GlyGluGluSerThrValArgPheAlaArgLysGlyAlaLeuArgGlnLysAsnValMisGluValLysAsnH~sLysPheThrAlaArgPhePheLysGlnProThrPheCysSerH~s 52 
TGCACCGACTTCATTTGGGGCTTCGGGAAACAGGGATTCCAGTGTCAAGTCTGCTGCTTTGTTGTACACAAGCGCTGCCATGAATTCGTCACGTTCTCCTGCCCTGGTGCAGACAAGGGC 
CysThrAspPheIleTrpGlyPheGlyLysGlnGlyPheGlnCysGlnValCysCysPheValValH~sLysArgCysH~sGluPheWalThrPheSerCysProGlyAlaAspLysGly 
960 
92 
CCGGCCTCTGATGACCCACGGAGCAAACACAAGTTTAAGATCCACACCTACTCCAGCCCTACCTTCTGTGACCACTGTGGATCACTGCTGTATGGGCTCATCCACCAGGGGATGAAATGC 1080 
ProAlaSerAspAspProArgSerLysHisLysPheLysIleH~sThrTyrSerSerProThrPheCysAspH~sCysGlySerLeuLeuTyrGlyLeulleH~sGlnGlyMetLysCys 132 
GACACCTGTATGATGAATGTCCACAAGCGCTGCGTGATGAACGTCCCCAGCCTCTGTGGCACCGACCACACAGAACGCCGTGGCCGCATCTACATCCAGGCCCACATCGACAGGGAGGTC 1200 
AspThrCysMetMetAsnValHisLysArgCysValMetAsnWalProSerLeuCysGlyThrAspHisThrGluArgArgGlyArgIleTyrlleGlnAlaHisIleAspArgGluVal 172 
CTCATCGTTGTTGTAAGAGATGCTAAAAATCTGGTACCTATGGACCCCAACGGCTTGTCAGATCCCTACGTAAAACTGAAACTGATCCCTGATCCCAAAAGTGAGAGCAAGCAGAAGACC 
LeuIleValValValArgAsPAlaLysAsnLeuValProM~tAspProAsnGlyLeuSerAspProTyrValLysLeuLysLeu~leProAspProLysSerGluSerLysGlnLysThr 
1320 
212 
AAGACTATCAAATGCTCCCTCAACCCGGAGTGGAACGAAACCTTCAGATTTCAGCTGAAGGAATCAGACAAAGACAGAAGACTGTCCGTAGAGATCTGGGATTGGGACCTGACCAGCAGG 1440 
LysThrlleLysCysSerLeuAsnProGluTrpAsnGluThrPheArgPheGlnLeuLysGluSerAspLysAspArgArgLeuSerValGluIleTrpAspTrpAspLeuThrSerArg 252 
AATGACTTCATGGGATCTCTGTCGTTTGGGATTTCAGAACTACAGAAAGCCGGAGTGGATGGCTGGTTCAAGTTAC~AAGCCAGGAAGAAGGCGAGTACTTTAATGTGCCGGTGCCGCCG 1560 
AsnAspPheMetGlySerLeuSerPheGlyIleSerGluLeuGlnLysAlaGlyValAspGlyTrpPheLysLeuLeuSerGlnGluGluGlyGluTyrPheAsnValProValProPro 292 
GAAGGAAGCGAGGGCAATGAAGAGCTGCGGCAGAAGTTTGAGAGAGCCAAGATTGGCCAAGGTACCAAGGCTCCAGAAGAAAAGACAGCGAACACTATATCCAAATTTGACAACAATGGC 1680 
GluGlySerGluGlyAsnGluGluLeuArgGlnLysPheGluArgAlaLyslleGlyGlnGlyThrLysAlaProGluGluLysThrAlaAsnThrIleSerLysPheAspAsnAsnGly 332 
AACAGGGACCGGATGAAACTGACCGATTTTAACTTCCTGATGGTGCTGGGGAAAGGCAGCTTTGGCAAGGTCATGCTCTCAGAGCGGAAGGGTACAGATGAACTCTATGCCGTGAAGATC 1800 
AsnArgAspArgMetLysLeuThrAspPheAsnPheLeuMetVa~LeuGlyLysGlySerPheGlyLysValMetLeuSerGluArgLysGlyThrAspGluLeuTyrAlaValLyslle 372 
CTGAAGAAAGATGTGGTGATCCAAGATGACGATGTGGAGTGCACAATGGTGGAGAAGAGGGTGCTGGCCCTGCCTGGGAAGCCCCCATTCCTGACTCAGCTCCATTCCTGCTTCCAGACC 1920 
LeuLysLysAspValWallleGlnAspAspAspValGluCysThrMetValGluLysArgValLeuAlaLeuPraGlyLysProProPheLeuThrGlnLeuHisSerCysPheGlnThr 412 
ATGGACCGCCTCTACTTTATGATGGAGTATGTGAACGGGGGTGACCTCATGTACCACATCCAACAAGTTGGCCGTTTCAAGGAGCCCCATGCTGTATTTTACGCTGCAGAGATTGCCATC 2040 
MetAspArgLeuTyrPheMetMetGluTyrValAsnGlyGlyAspLeuMetTyrH~s~leGlnGlnValGlyArgPheLysGluProH~sAlaValPheTyrAlaAlaGlu~leAlalle 452 
GGTCTTTTCTTCTTGCAGAGCAAGGGCATCATTTACCGTGACCTGAAACTTGACAACGTGATGCTGGATTCCGAGGGGCACATCAAAATCGCTGACTTTGGCATGTGTAAAGAGAATATC 2160 
GlyLeuPhePheLeuGlnSerLysGlylleTyrArgAspLeuLysLeuAspAsnValMetLeuAspSerGluGlyHislleLysIleAlaAspPheGlyMetCysLysGluAsnIle 492 
TGGGATGGGGTGACAACCAAGACATTCTGTGGCACTCCAGACTACATTGCCCCAGAGATCATTGCTTATCAGCCCTACGGGAAGTCTGTGGACTGGTGGGCGTTTGGAGTCCTGCTGTAT 2280 
TrpAspGlyValThrThrLysThrPheCysGlyThrProAspTyrlleAlaProGlu~lelleAlaTyrGlnProTyrGlyLysSerValAspTrpTrpAlaPheGlyValLeuLeuTyr 532 
GAAATGTTGGCTGGCCAGGCACCTTTTGAAGGGGAGGATGAGGATGAACTCTTCCAGTCAATCATGGAGCACAACGTGGCGTATCCCAAGTCCATGTCTAAGGAAGCTGTGGCAATCTGC 2400 
GluMetLeuAlaGlyGlnAlaProPheGluGlyGluAspGluAspGluLeuPheGlnSerIleMetGluH~sAsnValAlaTyrProLysSerMetSerLysGluAlaValAlalleCys 572 
AAAGGGCTAATGACCAAACACCCAGGCAAGCGCCTGGGTTGTGGGCCTGAAGGGGAACGAGACATTAAGGAGCATGCATTTTTCCGGTATATCGACTGGGAGAAACTCGAACGCAAGGAG 2520 
LysGlyLeuMetThrLysH~sProGlyLysArgLeuGlyCysGlyProGluGlyGluArgAspIleLysGluHisAlaPhePheArgTyrIleAspTrpGluLysLeuGluArgLysGlu 612 
ATTCAGCCACCTTATAAACCAAAAGCT7GTGGGCGAAACGCTGAAAACTTCGACCGGTTTTTCACCCGCCATCCACCAGTCCTAACACCTCCTGACCAGGAAGTCATCAGGAATATTGAC'2547(2640) 
CAATCAGAATTCGAAGGATTTTCCTTTG::AACTCTGAATTTTTAAAACCCGAAGTCAAGAGCTAAGTAGATCTGTAGACCTCCGTCCTTCATTTCTGTCATTCAAGCTCAACAGCTATC 2547(2760) 
GlnSerGluPheGluGlyPheSerPheValAsnSerGluPheLeuLysProGluValLysSerENO 621(673) 
ArgAspLysArgAspThrSerAsnPheAspLysGluPheThrArgGlnProValGluLeuTh~P~oThrAspLysLeuPhelleMetAsnLeuAspGlnAsnGluPheAlaGlyPhe 660 
622 
TCGTATACTAACCCAGAGTTTGTCATTAATGTGTAGGTGAATGCAGATTCCATCGCTGAGCCTGTGTGTAAGGCTGCAGGCTGAATGTCTATTATCAATTCCAGTCTTCCAGGATTCATG 2784(3000) 
SerTyrThrAsnProGluPheVallleAsnValENO 671 
GTGCCTCTGTTGGCATCCGTCATGTGGAGAGCTTGTCTTAGAGGGCTTTTCTTTGTATGTATAGCTTGCTAGTTTGTTTTCTACATTTCAAAATGTTTAGTTTAGAATAAGTGCATTGCC 2904(3120) 
CACTGATAGAGGTACAATTTTCCAGACTTCCAGAAACTCATCCAATGAACCAACAGTGTCAAAACTTAACTGTGTCCGATACCAAAATGCTTCAGTATTTGTAATTTTTAAAGTCAGATG 3024(3240) 
CTGATGTTCCTGGTCAAAGTTTTTACAGTTACTCTCGAATATCTCCTTTGAATGCTACCTAAGCATGACCGGTATTTTTAAAAGTTGTGAGTAAGCTTTGCAGTTACTGTGAACTCTTGT 3144(3360) 
CTCTTGGAGGAAACTTTTTGTTTAAGAATTGGTATGATTATGAATTCATATATGC(A)n 
Fig.2. Nucleotide sequence of rat brain protein kinase C type I cDNA and deduced amino acid sequence. The sequence 
of an additional 216 nucleotides of the type II cDNA clone is also given in the box. The numbers in the parentheses 
correspond to the type II cDNA. Potential polyadenylation signal is underlined. 
5 ‘-end of the cDNA, 684 nucleotides of un- 673 amino acids for type II beginning with a 
translated sequence are followed by the open methionine codon. Based on these cDNA se- 
reading frame of 671 amino acids for type I and quences, the Mr is estimated to be 76800 for type 
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I and 76900 for type II. These values match well 
the value that was previously estimated for the en- 
zyme by sucrose density gradient centrifugation 
analysis [4]. The coding regions of protein kinase 
C are followed by 504 nucleotides for type I and 
714 nucleotides for type II of 3 ‘-untranslated 
sequences containing the hexanucleotide 
ATTAAA (position 3181 for type I and position 
3397 for type II) which precedes the site of 
polyadenylation in most eukaryotic mRNAs. 
Four additional ATGs are found in the 
5 ‘-untranslated region at positions 309, 356, 396 
and 402. However, presumably none of these 
regions serves as the translational initiation site for 
the protein kinase, because three stop codons 
(positions 359,403 and 501), that are distributed in 
the three possible reading frames, occur in the 374 
nucleotides between these upstream ATGs and the 
putative translational initiation codon. It is known 
that the presence of upstream ATGs does not 
necessarily repress translational initiation at the 
proper starting site when it is followed by an in- 
frame termination codon [lo]. Thus the ATG at 
position 685-687 is most likely the initiation 
codon. 
3.3. Two types of cDNAs 
The sequence of type II is longer than that of 
type I by an insertion at 2547 (fig.2). In spite of 
this insertion into the coding region, the amino 
acid sequence deduced from the nucleotide se- 
quence of type II is only two amino acids longer 
than that of type I, due to the appearance of a ter- 
mination codon in the insertion region. 
During the course of screening of protein kinase 
C cDNA, several cDNA clones were isolated which 
may be derived from a single unspliced molecule. 
Out of these clones, pCKR41 and hCKR1 were 
analyzed more precisely. The nucleotide sequences 
of these two clones were compared with those of 
type I and type II protein kinase cDNAs. For 
pCKR41, the nucleotide sequence of the 3 ‘-region 
from position 2547 in fig.2 is completely identical 
to that of type I or type II cDNA, but that of the 
5 ‘-region from that position is different in each 
type. The sequence of the divergent point is 
TTTGGCAG/ which agrees with the consensus e- 
quence of the acceptor site of splicing [ 11,121. On 
the other hand, for XCKRI, the nucleotide se- 
quence of the 5 ’ -region from position 2547 in fig.2 
350 
is the same as that of type II cDNA, but that of the 
3 ‘-region is different from that of type II cDNA. 
The sequence of the divergent point is /GTGACA 
which agrees with the consensus sequence of the 
splicing donor site [11,12]. These results strongly 
suggest hat the additional sequence in the type II 
cDNA does not originate from the artificial recom- 
bination in the cDNA cloning experiment, but 
from an alternative splicing event as shown in 
fig.3a. Analysis of the genomic clones may provide 
more precise information. The production of dif- 
ferent polypeptides from a single gene by the alter- 
native splicing has also been observed in the case of 
immunoglobulins [13,14], calcitonin [15], 
preprotachykinin [ 161, troponin [ 171, and c-abl 
1181. 
The amino acid sequences of type I and type II, 
which are deduced from the nucleotide sequences 
of the divergent regions, exhibit a significant 
homology as shown in fig.3b. Conservation of the 
amino acid sequence of this region may indicate 
that this region may indicate that this region is an 
important domain which is related to the biological 
activity of protein kinase C. Both of the products 
of type I and type II cDNAs expressed in mam- 
a 
---L~SAIIA~gASp--- 
---AAAGCTAGAGAC--- Type I EDNA 
genome 
. .I 
, I I 5 
---AAAGCTTGTGGG--- ---A,CATGAGAGAC--- Type II cDNA 
---LyrAlaCysGly--- 
Fig.3. Divergent region between type I and type II of rat 
brain protein kinase C. (a) Model for the generation of 
type I and type II mRNA by alternative splicing. Boxes 
and lines indicate the putative exons and introns, respec- 
tively. Partial nucleotide sequences of the cDNA 
(pCKR41 and ACKRI) are shown, which seem to be 
derived from the unspliced molecule. (b) Comparison of 
the amino acid sequences of the divergent regions. Gaps 
indicated by hyphens are introduced to optimize 
homology. Stars indicate the amino acid residues which 
are common for the two sequences. 
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malian cultured cells showed Ca*+- and 
phospholipid-dependent protein kinase activity. 
The precise procedures for the expression of the 
enzyme will be described elsewhere. 
3.4. Comparison of protein kinase C with other 
protein kinases 
In most protein kinases, the catalytic domains 
appear to be located at the carboxyl-terminal 
regions of the polypeptide chains. Comparing the 
predicted amino acid sequence of protein kinase C 
with those of other protein kinases, it is clear that 
the protein kinase domain of protein kinase C is 
also located at the carboxyl-terminal region. Fig.4 
A-t,nare 1 
C-t,n4rc 303 
G-t,nare 315 
GNAAAAKK--GSEQE-SVK--EFL-AKA--KEDFLKKWENPAQNTANLOQFERlKTL--GT 
* 
QKFER;I--!E--~G-T-I4PEE*TIS~F~--NN-G~ROR--"~~T~~~FL"":--~K 
IORDSFKHLIGGLDD"SNKAYEDAE;KA--KYEAEAA--FFA-N-LKLSDFNIIDT;G"~- 
A-l;,narc 52 
C-kinarc 351 
G-trnase 369 
QITERy:~V--KHME--TGNH~~M~!~O~Q~-~~-KLKQI~H~L~-~-~~-lLQ-AV--NF 
* * * * 
GSFGKVMLSERKG----TOELVAVKIL-K-KDVVlQDDDVECT-NV~-K~-VL--ALPGKP 
l *t** * 1 *****t * 
G-FGRVELVQLKSEESKT---FAMKIL-K-K----RH--IVDTRQQEHlRSEKQI~GAHS 
A-trnare 101 
C-tinase 401 
G-tinasc 418 
PFLVKLEFS-FKDNSNLV-MIMEVVPGGE-MFSHLRRIGRESEPHA-RFVAAQIVLTFEVL 
ttt * t l *. * **** ** t * tt l t*t **t* * . 
PFLTQL-HSCFQTMORLVFM-MEYVNGGDLMY-nIQQVGRFKEPHA-VFVAAEIAIGLFFL 
I * f t* * ** ** * t** *** * 
DFIVRLVRT-FKDSKVLV-NLMEACLGGELYTI-LRDRGSF-EDSTTRFVTACVVEAFAVL 
A-kinase I58 
C-tinase 458 
G-tinare 475 
HSLDLIVRDLKPENLLIWQGVIQVTDFGFAKRVKGRTWTL---CGTPEVLAP~IlLSKGV 
* ***,.t * . t * *,* l " t*.* * t*tt* * 
QSKGlIVROLKLDNVMLOSEGHI~IA~~~C~ENINDGVTTKTFCGTPOVlAPEIlAVQPV 
tt******t* * I" * * *et*., * *t*** 
HSKGlIVROLKPENLILOHRGVAKLVDFGFAKKlGF-GKKTWTFCGTPEV~APEllLNKGH 
A-Kin& 216 
C-k.,nase 519 
G-t?nase 535 
NKAVOWALGVLIVEMAAGVPPFFAOQPIQIVEKIYSGKVRFPSHFSSD-LKDLLRNLLQV 
* ***** ttt l ** ** l * ** * * 
GKSVDWYAFGVLLVEMLAGQAPFEGEDEDELFQS~NE"NVAVPKS"SKE-AVAICKGLNTK 
t*t *a**** **** * * 
DISADVYSLGILMVELLTGSPPFSGPDPPKTVNIILRGIDMIEFPKKIAKNAANLIKKLCR 
A-kinase 276 
C-krmse 579 
G-l;,nare 596 
DLTK-RFGNLKDPVN~!*KN~KNFATTDWIAIVQRKVEA-PFIPKFKGPG~~~~~~DVEEEE 
"ff * ** ** * ** 
HPGK-RLGCGPEEER~!KE~AF~RVID~~K~E-RKEIQ~~VKPKARDKR~~~~~~KEFTRQ 
*** * 
DNPSERLGNLKNGVKDIQKHKWFEGFNYEGL-RKGTLTPPIIPSVASPTDTSNFDSFPEDN 
A-kinarc 335 IRVSINEKCGKEFSEF 
C-klnase 638 PVELTPTDKLFIMNLDQNEFAGFSVTNPEFVINV 
G-t1nase 656 DEPPPDDNSGWDID 
Fig.4. Comparison of the homologous regions among 
rat protein kinase C type I (C-kinase), catalytic subunit 
of bovine cyclic AMP-dependent protein kinase (A- 
kinase) [21], and bovine cyclic GMP-dependent protein 
kinase (G-kinase) [22]. Gaps indicated by hyphens are 
introduced to optimize homology. Stars indicate the 
amino acid residues which are common for these protein 
kinases. 
shows the amino acid sequences within the con- 
served region of three protein kinases. Large 
clusters of homology occur throughout the en- 
zymes. The lysine residue for the ATP-binding site 
is conserved in protein kinase C (amino acid 371), 
and a characteristic sequence of Gly-X-Gly-X-X- 
Gly is found 15-20 residues upstream from this 
binding site. This region is highly conserved in all 
protein kinases including tyrosine-specific protein 
kinases and is likely to be an important structural 
domain [9]. 
Since protein kinase C is a Ca*+- and 
phospholipid-dependent enzyme, there may be a 
Ca*+-binding site in the enzyme molecule. Recent- 
ly, Geisow [20] has found the consensus equence 
of the Ca*+-binding site by comparison of the 
amino acid sequences of various Ca*+-binding pro- 
teins. Searching for such a consensus sequence 
(Gly-X-Gly-Thr-Asp-Glu) in the predicted protein 
kinase C structure, an analogous sequence is 
located at amino acid residues 361-366. However, 
it may not be concluded at present hat this region 
is indeed the Ca*+-binding site of protein kinase C. 
Here, the primary structures of two types of rat 
brain protein kinase C are presented, which are 
deduced from the nucleotide sequences of several 
overlapping cDNA clones. The amino acid se- 
quences of the two types of protein kinase C differ 
from each other only in the carboxyl-terminal 
region, and this difference seems to result from 
alternative splicing. Since alternative splicing 
events are known to be related to the regulation of 
tissue specific gene expression,*it s suggestive that 
protein kinase C shows some tissue specificity. 
It has been reported [6] that digestion of rat 
brain protein kinase C with lysylendopeptidase 
produced a pair of closely similar amino acid se- 
quences, one of which is not coded by any of the 
cDNA clones described above. It is likely that an 
additional species of protein kinase C may occur in 
the brain tissue. Although it remains unclear 
whether several forms of this enzyme exist in a 
single cell or are derived from different cell types, 
it is attractive to imagine that various forms of 
protein kinase C may transduce different signal 
messages into the cell. 
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